Cetirizine Hydrochloride
NDC 16571-401, Cetirizine Hydrochloride, tablet, from Rising Pharma Holdings, Inc..
- Product NDC
- 16571-401
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA077829
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16571-401 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CETIRIZINE HYDROCHLORIDE5 mg/1
Pharmacologic classes
Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16571-401-10 | 16571040110 | 100 TABLET in 1 BOTTLE (16571-401-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
NADAC price for package 16571040110
GET /v1/drugs/nadac/16571040110
Use it
Look up 16571-401 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16571-401 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16571-401. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.